Plasma insulin-like growth factor-1 and binding protein-3 and subsequent risk of prostate cancer in the PSA era

By Platz Elizabeth   Pollak Michael  

Cancer Causes and Control, Vol. 16, Iss. 3, 2005-04 ,pp. : 255-262

Springer Publishing Company

Access to resources Recommend Favorite

In-utero exposures and breast cancer risk: joint effect of estrogens and insulin-like growth factor?

By Schernhammer E.S.  

Cancer Causes and Control, Vol. 13, Iss. 6, 2002-08 ,pp. : 505-508

Springer Publishing Company

Access to resources Recommend Favorite

Factors associated with circulating levels of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in 740 women at risk for breast cancer

By Johansson Harriet  

Breast Cancer Research and Treatment, Vol. 88, Iss. 1, 2004-11 ,pp. : 63-73

Springer Publishing Company

Access to resources Recommend Favorite

Association of circulating insulin-like growth factor 1 and insulin-like growth factor binding protein 3 with the risk of ovarian cancer: A systematic review and meta-analysis

By          

Molecular and Clinical Oncology, Vol. 3, Iss. 3, 2015-01 ,pp. : 623-628

Science Publishers

Access to resources Recommend Favorite

Type I Insulin-like Growth Factor Receptors in Human Colorectal Cancer

By Adenis A.   Peyrat J.-P.   Hecquet B.   Delobelle A.   Depadt G.   Quandalle P.   Bonneterre J.   Demaille A.  

European Journal of Cancer, Vol. 31, Iss. 1, 1995-01 ,pp. : 50-55

Elsevier

Access to resources Recommend Favorite